From £6.99 per month
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares


Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Results: SBI

Search articles by EPIC code

SourceBio International – proposed AIM cancellation and tender offer, why might there have been a lack of investor “attention”?

SourceBio International (SBI) has announced proposed cancellation of its, AIM, stock market listing and a “tender offer pursuant to which up to 11,071,810 ordinary shares (representing approximately 14.9 per cent. of the existing share capital of the company) would be purchased by the company at a price of 115 pence per ordinary share”. With the shares currently 110p and there 74,183,038 in issue, why is this proposed and what does it mean for shareholders?


This Baby Bio Firm is Growing Fast on Covid Testing, but the Upward Action Shouldn't Falter Once the Virus is Gone

Hello Share Mates. It might seem a little late in the day to commend to your further attention a company which tests for the virus. But a lot more of that sort of thing will be needed before the vaccines finally squash the disease. Unlike some companies which are thrashing around in the market, SourceBio International (SBI) has seen a big demand for its laboratory testing.

Page 1 of 1 (8 articles)
Subscribe to our newsletter

Daily digest of our latest stories.

Search ShareProphets

Complete Coverage

Recent Comments